BIOTELEMETRY, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Net income (loss)
OPERATING ACTIVITIES
Net income/(loss)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities
Bad debt expense
Depreciation
Amortization of intangibles
Depreciation and amortization
Impairment charge
Stock-based compensation
Equity method investment loss
Write off of derivative premium
Accretion of debt discount
Loss on extinguishment of debt
Gain on legal settlement
Non-cash lease (income)/expense
Deferred income taxes
Change in fair value of acquisition-related contingent consideration
Other non-cash items
Changes in operating assets and liabilities:
Healthcare and other accounts receivable
Inventory
Prepaid expenses and other assets
Accounts payable
Accrued and other liabilities
Liability associated with the Civil Investigative Demand
Net cash provided by operating activities
Net cash provided by operating activities
INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired
Purchases of property and equipment and investment in internally developed software
Purchase of derivative instrument
Investment in equity method investee
Proceeds related to the exercising of stock options and employee stock purchase plan
Net cash used in investing activities
FINANCING ACTIVITIES
Proceeds related to the exercising of stock options and employee stock purchase plan
Payments of tax withholdings related to vesting of share-based awards
Issuance of long-term debt
Borrowings under revolving loans
Repayments on revolving loans
Payment of debt issuance costs
Principal payments on long-term debt
Principal payments on finance lease obligations
Acquisition of noncontrolling interests
Net (decrease) increase in cash and cash equivalents
Effect of exchange rate changes on cash
Net cash (used in)/provided by financing activities

Effect of exchange rate changes on cash
Net (decrease)/increase in cash and cash equivalents
Cash and cash equivalents—beginning of period
Cash and cash equivalents—end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Non-cash purchases of property and equipment
Non-cash fair value of common stock returned in legal settlement
Non-cash fair value of equity issued for acquisition of business
Non-cash fair value of non-trade receivables exchanged for investment in equity method investee
Cash paid for interest
Cash paid for taxes, net of refunds

Comments